Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anthony J. Lembo, M.D.

Co-Author

This page shows the publications co-authored by Anthony Lembo and Lisa Conboy.
Connection Strength

1.135
  1. Conscientiousness is modified by genetic variation in catechol-O-methyltransferase to reduce symptom complaints in IBS patients. Brain Behav. 2015 Jan; 5(1):39-44.
    View in: PubMed
    Score: 0.149
  2. Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2010 Jul; 32(1):29-42.
    View in: PubMed
    Score: 0.108
  3. Which patients improve: characteristics increasing sensitivity to a supportive patient-practitioner relationship. Soc Sci Med. 2010 Feb; 70(3):479-484.
    View in: PubMed
    Score: 0.105
  4. A treatment trial of acupuncture in IBS patients. Am J Gastroenterol. 2009 Jun; 104(6):1489-97.
    View in: PubMed
    Score: 0.102
  5. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ. 2008 May 03; 336(7651):999-1003.
    View in: PubMed
    Score: 0.094
  6. A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome. Neurogastroenterol Motil. 2007 Aug; 19(8):630-7.
    View in: PubMed
    Score: 0.090
  7. Investigating placebo effects in irritable bowel syndrome: a novel research design. Contemp Clin Trials. 2006 Apr; 27(2):123-34.
    View in: PubMed
    Score: 0.081
  8. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil. 2005 Jun; 17(3):332-40.
    View in: PubMed
    Score: 0.077
  9. Are they side effects? Extra-intestinal symptoms reported during clinical trials of IBS may be more severe at baseline. Clin Gastroenterol Hepatol. 2022 Mar 23.
    View in: PubMed
    Score: 0.062
  10. Patients' experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study. BMC Psychol. 2022 Feb 04; 10(1):20.
    View in: PubMed
    Score: 0.062
  11. Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial. Trials. 2017 05 25; 18(1):234.
    View in: PubMed
    Score: 0.044
  12. Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One. 2012; 7(10):e48135.
    View in: PubMed
    Score: 0.032
  13. Serum correlates of the placebo effect in irritable bowel syndrome. Neurogastroenterol Motil. 2010 Mar; 22(3):285-e81.
    View in: PubMed
    Score: 0.027
  14. "Maybe I made up the whole thing": placebos and patients' experiences in a randomized controlled trial. Cult Med Psychiatry. 2009 Sep; 33(3):382-411.
    View in: PubMed
    Score: 0.026
  15. Patient and practitioner influences on the placebo effect in irritable bowel syndrome. Psychosom Med. 2009 Sep; 71(7):789-97.
    View in: PubMed
    Score: 0.026
  16. Adequate relief in a treatment trial with IBS patients: a prospective assessment. Am J Gastroenterol. 2009 Apr; 104(4):912-9.
    View in: PubMed
    Score: 0.025
  17. Effectiveness of recruitment in clinical trials: an analysis of methods used in a trial for irritable bowel syndrome patients. Contemp Clin Trials. 2008 Mar; 29(2):241-51.
    View in: PubMed
    Score: 0.023
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.